Dr. Stephen Freedland, MD

• Urology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of California At Berkeley

  Medical School, 1997

• Baseline Subject Characteristics Predictive of Compliance with Study-Mandated Prostate Biopsy in Men at Risk of Prostate Cancer: Results from REDUCE, 2016-03-01

• A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts, 2018-05-16

• The Streaming Web-Based Exercise at Home Study for Breast and Prostate Cancer Survivors: A Feasibility Study Protocol, 2023-05-17

• A comparative study of PCS and PAM50 prostate cancer classification schemes, 2021-02-02

• Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model, 2017-03-28

• Factors Predicting Skeletal-Related Events in Patients With Bone Metastatic Castration-Resistant Prostate Cancer, 2016-12-27

• Prediction of pancreatic cancer in diabetes patients with worsening glycemic control, 2021-11-02

• Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs Cohort Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy, 2021-06-03

• First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: Results from SEARCH, 2019-01-30

• The misdiagnosis of interstitial cystitis/bladder pain syndrome in a VA population, 2019-07-14

• Metformin Use and Risk of Prostate Cancer: Results from the REDUCE Study, 2015-09-09

• Validity of the National Death Index to Ascertain the Date and Cause of Death in Men Having Undergone Prostatectomy for Prostate Cancer, 2019-04-29

• Positive Surgical Margins in Radical Prostatectomy Patients Do Not Predict Long-term Oncological Outcomes: Results from SEARCH, 2015-06-23

• Exposure to Agent Orange and Risk of Bladder Cancer Among US Veterans Exposure to Agent Orange and Risk of Bladder Cancer Among US Veterans, 2023-06-27

• Food Sensitivities in a Diverse Nationwide Cohort of Veterans with Interstitial Cystitis/Bladder Pain Syndrome, 2022-08-24

• Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model, 2016-11-30

• Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCH, 2016-08-31

• Racial differences in prostate inflammation: results from the REDUCE study, 2016-07-18

• Quality-of-life impact of interstitial cystitis and other pelvic pain syndromes, 2023-05-25

• Impact of Psychiatric Illness on Decreased Survival in Elderly Patients with Bladder Cancer in the United States, 2018-04-16

• Transcriptomic heterogeneity of androgen receptor (AR) activity defines ade novolow AR-active subclass in treatment naive primary prostate cancer, 2019-09-12

• Predictors of Skeletal Related Events and Mortality in Men with Metastatic, Castration-Resistant Prostate Cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database, 2019-08-07

• The impact of race on survival in metastatic prostate cancer: a systematic literature review, 2023-08-17

• Impact of Diagnosing Urologists and Hospitals on the Use of Radical Cystectomy, 2020-06-23

• Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer, 2018-08-17

• Characterizing Molecular Subtypes of High-Risk Non-Muscle-Invasive Bladder Cancer in African American Patients, 2022-05-23

• The Association Between Phosphodiesterase Type-5 Inhibitors and Prostate Cancer: Results from the REDUCE Study, 2016-04-05

• Vasectomy: potential links to an increased risk of aggressive prostate cancer?, 2015-09-07

• Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort, 2021-12-31

• Race and Risk of Metastases and Survival after Radical Prostatectomy: Results from the SEARCH Database, 2017-06-27

• MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer, 2019-02-25

• Treatment patterns and survival in metastatic castration-sensitive prostate cancer in the US Veterans Health Administration, 2021-11-02

• Validation of the 2015 Prostate Cancer Grade Groups for Predicting Long-Term Oncologic Outcomes in a Shared Equal-Access Health System, 2017-06-29

• Sleep quality and prostate cancer aggressiveness: Results from the REDUCE Trial, 2020-08-24

• Accommodating heterogeneous missing data patterns for prostate cancer risk prediction, 2022-07-21

• Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer, 2021-07-16

• Statin use is associated with lower risk of PTEN-null and lethal prostate cancer, 2019-11-21

• Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools, 2019-10-15

• Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy, 2017-12-10

• Implications of Regionalizing Care in the Developing World: Impact of Distance to Referral Center on Compliance to Biopsy Recommendations in a Brazilian Prostate Cancer Screening Cohort, 2021-06-22

• Predictors of Time to Metastasis in Castration-resistant Prostate Cancer, 2016-06-16

• ONECUT2 is a Targetable Master Regulator of Lethal Prostate Cancer that Suppresses the Androgen Axis, 2018-11-26

• Combination Androgen Receptor Inhibition and Docetaxel in Metastatic Castration-sensitive Prostate Cancer: The Next Step in First-line Treatment?, 2020-05-11

• Survival Differences Among Bladder Cancer Patients According to Gender: Critical Evaluation of Radical Cystectomy Use and Delay to Treatment, 2017-06-21

• Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD, 2022-01-17

• Obese Castration-Resistant Prostate Cancer Patients may be at a lower risk of all-cause mortality: Results from the SEARCH Database, 2018-04-10

• Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease, 2017-03-30

• Prediction of Pancreatic Cancer in Diabetes Patients with Worsening Glycemic Control, 2021-11-02

• The prevalence and prognosis of next-generation therapeutic targets in metastatic castration-resistant prostate cancer J. Pan et al., 2022-10-20

• Prevalence of Overactive Bladder Symptoms Among Women with Interstitial Cystitis/Bladder Pain Syndrome, 2022-03-01

• Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study, 2017-12-27

• Modified Risk Stratification Grouping Using Standard Clinical and Biopsy Information for Patients Undergoing Radical Prostatectomy: Results from SEARCH, 2017-10-10

• Statin use and longitudinal changes in prostate volume; results from the REDUCE trial, 2019-09-27

• Does Larger Tumor Volume Explain the Higher Prostate Specific Antigen Levels in Black Men with Prostate Cancer -Results from the SEARCH Database, 2015-10-06

• Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database, 2016-10-04

• Treatment patterns for older veterans with localized prostate cancer, 2015-07-27

• A transcriptional regulatory loop of master regulator transcription factors, PPARG, and fatty acid synthesis promotes esophageal adenocarcinoma, 2021-01-05

• Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features, 2017-04-08

• Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes, 2021-02-10

• National prevalence of IC/BPS in women and men utilizing veterans health administration data, 2022-08-24

• Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy, 2021-03-09

• Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study, 2020-01-13

• Racial differences in the association between preoperative serum cholesterol and prostate cancer recurrence: results from the SEARCH database, 2016-01-25

• Does race predict development of metastases in men on ADT after biochemical recurrence following radical prostatectomy?, 2018-11-14

• Increased Utilization of Positron Emission Tomography-Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed with Bladder Cancer, 2017-07-26

• Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review, 2022-08-03

• Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer, 2016-02-08